Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6822480 | Schizophrenia Research | 2017 | 8 Pages |
Abstract
In conclusion, the novel dopamine serotonin stabilizer, RP5063 is an efficacious and well-tolerated treatment for acute exacerbation of schizophrenia or schizoaffective disorder.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Marc Cantillon, Arul Prakash, Ajay Alexander, Robert Ings, Dennis Sweitzer, Laxminarayan Bhat,